(19)
(11)
EP 0 655 924 A1
(12)
(43)
Date of publication:
07.06.1995
Bulletin 1995/23
(21)
Application number:
93906955.0
(22)
Date of filing:
21.10.1992
(51)
International Patent Classification (IPC):
C12N
15/
02
( . )
A61P
35/
00
( . )
C07K
16/
32
( . )
A61K
38/
00
( . )
A61K
39/
395
( . )
C07K
16/
30
( . )
C12P
21/
08
( . )
(86)
International application number:
PCT/US1992/008545
(87)
International publication number:
WO 1994/000136
(
06.01.1994
Gazette 1994/02)
(84)
Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE
(30)
Priority:
30.06.1992
US 19920906555
(71)
Applicant:
ONCOLOGIX, INC.
Gaithersburg, MD 20878 (US)
(72)
Inventors:
KASPRZYK, Philip, G.
Washington, DC 20010 (US)
KING, Charles, R.
Washington, DC 20010 (US)
(74)
Representative:
Weisert, Annekäte, Dipl.-Ing. Dr.-Ing.
Patentanwälte Kraus Weisert & Partner Thomas-Wimmer-Ring 15
D-80539 München
D-80539 München (DE)
(54)
A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING